"We are excited about the IND filing in the US for the internally developed TG-1000 which has the potential to be a single dose treatment for influenza."
100420 TaiGen filed US IND for its influ
.
Download • 42KB
top of page
Medical and Pharma Insider
Medical - Pharma - Biotech - Medical Devices - Healthcare - Telemedicine - Healthcare Technology - Healthcare IT
Your Source For Worldwide Business and Financial Opportunities
-
MedNews on financings, strategic relationships, products, services and technology, including launches
-
MedTalks videos featuring conversations with management of companies with business or financial objectives
.jpg)
bottom of page